MedPath

CORZYNA

CORZYNA

Approved
DIN Number

02510227

Drug Class

Human

Market Date

May 24, 2023

Company
HC

kye pharmaceuticals inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02510227
AIG Number0162681002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C01EB18 RANOLAZINE
Product Specifications
Dosage FormTablet (Extended-Release)
Route of AdministrationOral
AHFS Classification24:04.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

RANOLAZINEActive
Strength: 1000 MG
Monograph: RANOLAZINE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.